Critical analysis of overdiagnosis in breast cancer screening. Risk-adapted screening protocols may optimize benefit-harm ratio. - https://www.aerzte-notdienst.de/georgsmarienhuette/isa-klose-6602325.html , Comprehensive analysis of biosimilars and their impact on healthcare costs. .